Treatment of Low-Risk Submassive Pulmonary Embolism With FlowTriever

NCT05273762 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2023-12-28

No results posted yet for this study

Summary

This study is focused on investigating the efficacy and safety of the FlowTriever device to treat low-risk submassive pulmonary embolism.

Conditions

Interventions

DEVICE

FlowTriever

Mechanical thrombectomy for pulmonary embolism

Sponsors & Collaborators

  • Inari Medical

    collaborator INDUSTRY
  • Northwell Health

    lead OTHER

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-01-25
Primary Completion
2024-07-01
Completion
2024-07-25
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05273762 on ClinicalTrials.gov